GNS Collaborated with Servier to Advance Drug Discovery and Clinical Development for Multiple Myeloma Using AI
Shots:
- The companies collaborated to advance drug discovery, translational, and clinical development efforts for MM by using AI and biosimulation along with other digital initiatives
- The collaboration will utilize GNS' Digital Twin and unique causal AI models to accelerate the research and early development to address the need of patients with MM
- GNS' MM Digital Twin has been developed using the rich clinico-genomic data from the MMRF (CoMMpass) study to develop a precise, quantifiable, transparent representation of complex biological mechanisms, uncovering new disease circuitry in humans
Ref: PRNewswire | Image: GNS
Click here to read the full press release
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.
